Chem Holdings

Member Since : 2012 | United Kingdom

BONVIVA Injection (3mg/3ml)


BONVIVA Injection (3mg/3ml)

Bonviva injection
of 3 ml solution contains 3 mg ibandronic acid (as sodium monohydrate). The concentration of ibandronic acid in the solution for injection is 1mg per ml.

Treatment of osteoporosis in postmenopausal women at increased risk of fracture.

A reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.

Metabolic interactions are not considered likely, since ibandronic acid does not inhibit the major human hepatic p450 isoenzymes and has been shown not to induce the hepatic cytochrome p450 system in rats. Ibandronic acid is eliminated by renal excretion only and does not undergo any biotransformation.

On the basis of the pharmacodynamic and pharmacokinetic profile and reported adverse reactions, it is expected that
bonviva
has no or negligible influence on the ability to drive and use machines.




Looking for BONVIVA Injection (3mg/3ml)


Describe your requirement in detail.

Enter Your Email

Enter Your Name

Enter Your Company Name

City

Enter Your Mobile No.

Send quotes from matching suppliers as well.

Promote this Page


Search



Contact Details

Mr. Lauden

#54 Overbury Road, London, , United Kingdom

View Mobile No.